Short answer
Ardent Health, Inc. (ARDT) filed its Q3 2025 10-Q quarterly report on Nov 14, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $1.6B (up 8.8% year over year) with net income of −$23M.
Q3 2025 key financials · XBRL
- Revenue
- $1.6B
- +8.8% YoY · −4.2% QoQ
- Net income
- −$23M
- −189.2% YoY · −132.2% QoQ
- EPS (diluted)
- −$0.17
- −189.5% YoY · −132.7% QoQ
Source: XBRL data from the Ardent Health, Inc. (ARDT) Q3 2025 10-Q on SEC EDGAR. USD.
Ardent Health, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Term Loan B refinanced at $777.5 million, extending maturity to September 2032
- Headwinds: Medicaid reductions, ACA subsidy expiration, labor shortages, inflation, and potential Medicare cuts up to 4% in early 2026
Risk Factors
- No material risk-factor changes from the Annual Report
- Regulatory and compliance risks carried forward without quarterly updates
- Operational and competitive risks carried forward without quarterly updates
- Financial risks carried forward without quarterly updates
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Ardent Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.